Acro Biomedical (ACBM) EBIT (2016 - 2025)
Acro Biomedical (ACBM) recorded quarterly EBIT of -$16377.0 in Q4 2025, up 85.77% quarter-over-quarter from -$115099.0 in Q3 2025, and down 183.52% on a YoY basis from $19608.0 in Q4 2024.
Acro Biomedical (ACBM) EBIT (2016 - 2025) Analysis & Trends
Acro Biomedical's EBIT history runs 10 years deep, the most recent figure standing at -$16377.0 for Q4 2025.
- In Q4 2025, EBIT fell 183.52% year-over-year to -$16377.0; the TTM figure through Dec 2025 stood at -$154024.0 (down 1634.11% YoY), while the FY2025 annual figure was -$154024.0, down 1634.11% from the prior year.
- EBIT was -$16377.0 for Q4 2025 at Acro Biomedical, up from -$115099.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of $6.9 million in Q4 2023 to a low of -$4.0 million in Q3 2022.
- Historically, EBIT has averaged -$1.3 million across 5 years, with a median of -$454209.5 in 2021.
- The sharpest annual moves came in 2022 and 2023: EBIT tumbled 6793.35% in 2022, then surged 276.35% in 2023.
- A 5-year view of EBIT shows it stood at -$3.9 million in 2021, then declined by 2.11% to -$3.9 million in 2022, then soared by 276.35% to $6.9 million in 2023, then slumped by 99.72% to $19608.0 in 2024, then plunged by 183.52% to -$16377.0 in 2025.
- The last three EBIT figures came in at -$16377.0 (Q4 2025), -$115099.0 (Q3 2025), and -$13614.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | -427,850.00 |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -84,204.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -482,100.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | -1.15 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | -201,744.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -225,545.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -612,993.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | -198,194.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | -966,218.00 |
| 10 | Acro Biomedical | - | - | - | -16,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16,377.00 |
| Sep 30, 2025 | -115,099.00 |
| Jun 30, 2025 | -13,614.00 |
| Mar 31, 2025 | -8,934.00 |
| Dec 31, 2024 | 19,608.00 |
| Sep 30, 2024 | -9,106.00 |
| Jun 30, 2024 | -9,086.00 |
| Mar 31, 2024 | -10,298.00 |
| Dec 31, 2023 | 6.94 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.19 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -793,320.00 |
| Mar 31, 2021 | -56,991.00 |